Literature DB >> 2930458

Solubilization of stable adenosine A1 receptors from rat brain.

S M Helmke1, D M Cooper.   

Abstract

Despite numerous reports of solubilization of adenosine A1 receptors, little progress has been made in isolating or purifying the receptor, owing to the extreme lability of the preparations. The present solubilization strategies recognized the possible role of endogenous adenosine to produce adenosine-receptor-N-protein complexes, which are intrinsically unstable, and instead attempted to use caffeine to solubilize free adenosine receptors, which might be more stable. Endogenous adenosine was removed from membranes by using adenosine deaminase along with GTP to accelerate the release of receptor-bound adenosine. The receptors were then occupied with caffeine and solubilized with 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulphonate (CHAPS) in the presence of glycerol. These soluble preparations exhibited the characteristics of free adenosine receptors. They bound the A1-selective antagonist 8-cyclopentyl-1,3-dipropylxanthine (CPDPX) with high affinity to a single class of binding sites, which were insensitive to GTP. The binding activity was extremely stable, with a half-life of about 5 days at 4 degrees C; there was little change in either receptor number or affinity during 3 days at 4 degrees C. This methodology should greatly facilitate the characterization, isolation and purification of the adenosine A1 receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930458      PMCID: PMC1135595          DOI: 10.1042/bj2570413

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Adenosine deaminase from Escherichia coli.

Authors:  P Nygaard
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

3.  Reconstitution of membrane processes.

Authors:  E Racker
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

4.  An accurate and convenient organic phosphorus assay.

Authors:  C W McClare
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

5.  Reconstitution of the receptor for immunoglobulin E into liposomes. Conditions for incorporation of the receptor into vesicles.

Authors:  B Rivnay; H Metzger
Journal:  J Biol Chem       Date:  1982-11-10       Impact factor: 5.157

6.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

7.  Solubilized adenosine receptors in the brain: regulation of guanine nucleotides.

Authors:  M Gavish; R R Goodman; S H Snyder
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

8.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

9.  Evidence that a beta-adrenergic receptor-associated guanine nucleotide regulatory protein conveys guanosine 5'-O-(3-thiotriphosphate)- dependent adenylate cyclase activity.

Authors:  J M Stadel; R G Shorr; L E Limbird; R J Lefkowitz
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

10.  Phospholipids stabilize the interaction between the alpha and beta subunits of the solubilized receptor for immunoglobulin E.

Authors:  B Rivnay; S A Wank; G Poy; H Metzger
Journal:  Biochemistry       Date:  1982-12-21       Impact factor: 3.162

View more
  2 in total

1.  Affinity chromatography of the bovine cerebral cortex A1 adenosine receptor.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  FEBS Lett       Date:  1989-11-06       Impact factor: 4.124

2.  Solubilized rabbit striatal A2a-adenosine receptors: stability and antagonist binding.

Authors:  X D Ji; K A Jacobson
Journal:  Arch Biochem Biophys       Date:  1993-09       Impact factor: 4.013

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.